A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient’s own body into a powerful weapon against cancer.
Researchers at the university’s Jonsson Comprehensive Cancer Centre are reinforcing the immune system’s foundation by genetically modifying bone marrow stem cells, the cellular factories that power immune responses. By arming those cells with receptors that recognise cancer, researchers hope a patient’s body will then cure itself from the inside out.
WideCells Group PLC (LON:WDC) is committed to making a difference in the world of family health protection; working hard to build the next generation of stem cell and cord blood banking companies – providing individuals and families access to affordable stem cell treatments globally.